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The adverse effect of medication is an important concern in
medical practice. It is the role of all medical personnel to provide
safe medical service to all patients and the prevention of the
episode of drug allergy is a focus in hospital accreditation[1,2].
Here, the authors would like to discuss on the problem of
acute drug allergy after getting medical treatment from a
primary care unit (due to privacy reason, the name is hereby
blinded). Within 1-year study period (2014), there are 2
incidences. One case is the new detected drug allergy to
penicillin and the second case is the repeated allergy to
cotrimoxazole. Of interest, although the repeated prescription
notiﬁcation is implemented in this center, the incidence can
still be detected. In the previous recent report by Wiwanitkit,
the repeated prescription of known identiﬁed drugs with a
history of drug allergy could be seen in 0.19% and the
repeated prescription notiﬁcation could be helpful for detection
of the repeated prescription before the actual problem of drug
allergy occurred[1].
However, the occurrence of the problem in this study requires
root cause analysis for proper preventive action. The explanation
for the ﬁrst case is simple. It is not possible to detect the ﬁrst
time of drug allergy and there can be no history of drug allergy
in this case. For sure, the repeated prescription notiﬁcation can
be useless. For the second case, it is very interesting. In detail,
the case is visited to the center and asked for a rapid by-pass
service. She had her friend registered for hospital number and
was bypassed by the nurse in-charge to visit the physician incharge. She did not note to the physician that she had history of
drug allergy to sulfa antibiotic when the physician in charge
asked her and she got prescription with cotrimoxazole. Also, she
did not note to the physician that she had history of drug allergy
to sulfa antibiotic when the pharmacist in charge asked her. She
took the drug and got the acute reaction presenting with burnt lip
and returned to the medical center. Of interest, at this time, it
was appeared that there is a record of previous drug allergy in
her out-patient department card, which was previously registered
by her friend and her friend gave the her history of drug allergy
already. This can reﬂect that if there is no patient compliance for
prevention and if there is no strict control of hospital registra-
tion, the problem can be expected. The bypass system to serve
the patient might seem good for satisfying the patient but it can
also cause the risk. To have a good clinical practice, the standard
management is warranted.
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